NTI drug but with high CV [Power / Sample Size]

posted by Mikalai  – Belarus, 2019-12-14 16:39 (1789 d 08:42 ago) – Posting: # 20975
Views: 3,847

Dear all.
What would be a sample size for a BE study when the CV of the drug is 30% but bioequivalence should be in range 90_110%? Our assumption is around 400 subject if the design is standard, and 200 if the design is replicative
Best regards.

Complete thread:

UA Flag
Activity
 Admin contact
23,288 posts in 4,890 threads, 1,659 registered users;
82 visitors (0 registered, 82 guests [including 11 identified bots]).
Forum time: 01:22 CET (Europe/Vienna)

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5